NephRx Corporation Leading the Discovery & Development of Therapeutic Products
Leading the Discovery & Development of Therapeutic Products

NX001

Our Renal Peptide fulfilling an unmet need Learn More

NX002

Our Gastric Peptide focusing on mucositis Learn More

 

NephRx News

BRCC invests additional $200,000 in NephRx

The Biosciences Research and Commercialization Center (BRCC), announced it’s continuing support of NephRx Corporation by providing $200,000 in additional funding for dev .... Read more

Patrick Morand joins NephRx Board of Directors

Patrick G. Morand is Managing Director of the SWMF Life Science Fund, headquartered in Kalamazoo, Michigan. Prior to joining the Fund, Mr. Morand was Executive in Residen .... Read more